Quick Takeaways
- Lombard Odier Asset Management (USA) Corp filed SCHEDULE 13G/A for Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares") (SLN).
- Disclosed ownership: 7.6%.
- Date of event: 31 Dec 2024.
Lombard Odier Asset Management (USA) Corp - 31 Dec 2024 SCHEDULE 13G/A Report for Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares") (SLN)
- Filing Manager
- Lombard Odier Asset Management (USA) Corp
- Reporting Manager
- Lombard Odier Asset Management (USA) Corp
- Symbol
- SLN
- Shares outstanding
- 140,968,776 shares
- Disclosed Ownership
- 10,713,627 shares
- Ownership
- 7.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 11 Feb 2025, 18:41:36 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 09 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Lombard Odier Asset Management (USA) Corp disclosed 7.6% ownership in Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares") (SLN) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Feb 2025, 18:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lombard Odier Asset Management (USA) Corp | 7.6% | 10,713,627 | 0 | 10,713,627 | /s/ Elyse Strauss | Authorized Signatory |